Literature DB >> 12665997

The impact of critical care pharmacists on enhancing patient outcomes.

Sandra L Kane1, Robert J Weber, Joseph F Dasta.   

Abstract

The highly specialized knowledge and skills needed to care for critically ill patients requires a multidisciplinary team approach. Pharmacists are integral members of this team. They make valuable contributions to improve clinical, economic, and humanistic outcomes of patients. The purpose of this article is to review the literature pertaining to pharmacists' contributions within a multidisciplinary intensivist-led intensive care unit (ICU) team. Pharmacist interventions include correcting/clarifying orders, providing drug information, suggesting alternative therapies, identifying drug interactions, and therapeutic drug monitoring. Pharmacist involvement in improving clinical outcomes of critically ill patients is associated with optimal fluid management and substantial reductions in the rates of adverse drug events, medication administration errors, and ventilator-associated pneumonia. Furthermore, economic evaluations of clinical pharmacy services in the ICU consistently reveal the potential for considerable cost savings.

Entities:  

Mesh:

Year:  2003        PMID: 12665997     DOI: 10.1007/s00134-003-1705-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  59 in total

1.  Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop.

Authors:  G D Rubenfeld; D C Angus; M R Pinsky; J R Curtis; A F Connors; G R Bernard
Journal:  Am J Respir Crit Care Med       Date:  1999-07       Impact factor: 21.405

2.  [Israel hospital pharmaceutical services: a national survey].

Authors:  S Livny; A Hammerman; S Shani; J Shemer
Journal:  Harefuah       Date:  2000-05-15

3.  Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome.

Authors:  G Schelling; C Stoll; M Haller; J Briegel; W Manert; T Hummel; A Lenhart; M Heyduck; J Polasek; M Meier; U Preuss; M Bullinger; W Schüffel; K Peter
Journal:  Crit Care Med       Date:  1998-04       Impact factor: 7.598

Review 4.  Evolving role of the pharmacist in the critical care environment.

Authors:  J F Dasta
Journal:  J Clin Anesth       Date:  1996-05       Impact factor: 9.452

5.  Short Form 36 in the intensive care unit: assessment of acceptability, reliability and validity of the questionnaire.

Authors:  P S Chrispin; H Scotton; J Rogers; D Lloyd; S A Ridley
Journal:  Anaesthesia       Date:  1997-01       Impact factor: 6.955

6.  National survey of critical-care pharmaceutical services.

Authors:  J F Dasta; R Segal; A Cunningham
Journal:  Am J Hosp Pharm       Date:  1989-11

7.  Medication administration errors in adult patients in the ICU.

Authors:  A D Calabrese; B L Erstad; K Brandl; J F Barletta; S L Kane; D S Sherman
Journal:  Intensive Care Med       Date:  2001-10       Impact factor: 17.440

8.  Quality of life 6 months after intensive care: results of a prospective multicenter study using a generic health status scale and a satisfaction scale.

Authors:  D Hurel; P Loirat; F Saulnier; F Nicolas; F Brivet
Journal:  Intensive Care Med       Date:  1997-03       Impact factor: 17.440

9.  Methods to assess the humanistic outcomes of clinical pharmacy services.

Authors:  K M Bungay
Journal:  Pharmacotherapy       Date:  2000-10       Impact factor: 4.705

10.  Impact of therapeutic drug monitoring of intravenous theophylline regimens on serum theophylline concentrations in the medical intensive care unit.

Authors:  W E Dager; T E Albertson
Journal:  Ann Pharmacother       Date:  1992-10       Impact factor: 3.154

View more
  51 in total

1.  How critical are critical care pharmacists?

Authors:  Clarence Chant
Journal:  Can J Hosp Pharm       Date:  2012-01

2.  [Not Available].

Authors:  Clarence Chant
Journal:  Can J Hosp Pharm       Date:  2012-01

3.  Medication error reporting systems: a survey of canadian intensive care units.

Authors:  Kimberley Louie; Amanda Wilmer; Hubert Wong; Maja Grubisic; Najib Ayas; Peter Dodek
Journal:  Can J Hosp Pharm       Date:  2010-01

4.  The importance of a judicious and early empiric choice of antimicrobial for methicillin-resistant Staphylococcus aureus bacteraemia.

Authors:  N Shime; T Kosaka; N Fujita
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-14       Impact factor: 3.267

5.  Clinical pharmacists and basic scientists: do patients and physicians need this collaboration?

Authors:  Amir H Zargarzadeh; Susan Jacob; Roger S Klotz; Fadi T Khasawneh
Journal:  Int J Clin Pharm       Date:  2011-12

6.  International critical care hospital pharmacist activities.

Authors:  Jaclyn M LeBlanc; Enrique C Seoane-Vazquez; Trudy C Arbo; Joseph F Dasta
Journal:  Intensive Care Med       Date:  2007-11-07       Impact factor: 17.440

7.  Medical and nursing staff highly value clinical pharmacists in the emergency department.

Authors:  Rollin J Fairbanks; James M Hildebrand; Karen E Kolstee; Sandra M Schneider; Manish N Shah
Journal:  Emerg Med J       Date:  2007-10       Impact factor: 2.740

8.  How to increase return on investment of the intensive care pharmacist - fear of flying.

Authors:  Michael Hartmann; Andreas Meier-Hellmann
Journal:  Intensive Care Med       Date:  2006-02-16       Impact factor: 17.440

Review 9.  The Economic and Humanistic Burden of Severe Sepsis.

Authors:  Bogdan Tiru; Ernest K DiNino; Abigail Orenstein; Patrick T Mailloux; Adam Pesaturo; Abhinav Gupta; William T McGee
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

10.  Clinical pharmacy faculty interventions in a pediatric intensive care unit: an eight-month review.

Authors:  Joseph M Larochelle; Marina Ghaly; Amy M Creel
Journal:  J Pediatr Pharmacol Ther       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.